Zusammenfassung
Da die chirurgische Behandlung zur Diagnosestellung, Dekompression und Tumorreduktion an erster Stelle der therapeutischen Maßnahmen steht, wird die Strahlentherapie vorwiegend postoperativ eingesetzt. Deswegen ist sie als alleinige Behandlungsmodalität schwierig beurteilbar, da nach unserem Wissen noch nie eine randomisierte Studie durchgeführt wurde, in welcher die Radiotherapie nach nur stereotaktischer Nadelbiopsie mit der Bestrahlung nach vorangegangener partieller oder totaler Resektion verglichen wurde. Nach unseren Erfahrungen mit der im Kap. IV beschriebenen Pilotstudie, in der die Patienten präoperativ bestrahlt wurden, wäre eine solche Studie wegen der auch mit hochdosierten Steroiden oft nur schwierig kontrollierbaren Hirndrucksteigerung wenig erfolgversprechend. Die Wirkung einer postoperativen Strahlentherapie dagegen ist gut bekannt. Das mittlere progressionsfreie Intervall nach Operation und Nachbestrahlung beträgt rund 6–9 Monate (Tabelle 17) und die mittlere Überlebenszeit 9–12 Monate (Tabelle 16). Auch die Indikation zur postoperativen Strahlentherapie ist heute nicht mehr umstritten. Eine retrospektive Sammelstatistik (116) mit 1258 Patienten, die wegen undifferenzierter Astrozytome operiert oder operiert und bestrahlt wurden, ergab eine Rate klinisch Geheilter von 0,6% (4/649) der allein operierten und von 4% (26/609) der operierten und bestrahlten Patienten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams GE (1973) Clinical radiosensitization of hypoxic cells. Br Med Bull 29:48–53
Adams GE, Dewey DL (1963) Hydrated electrons and radiobiological sensitation. Biochem Biophys Res Commun 12:473–481
Andrews JR (1978) The radiobiology of human cancer radiotherapy, 2nd edn. University Park Press, Baltimore
Aristizabal SA, Caldwell WL (1971) Time-dose volume relationships in the treatment of glioblastoma multiforme. Radiology 101:201–202
Aristizabal S, Caldwell WL, Avila J (1977) The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys 2:667–673
Arnold A, Bailey P, Laughlin JS (1954) Effects of betatron radiations in the brain of primates. Neurology (NY) 4:165–178
Asquith JC, Foster JL, Willson RL (1974) Metronidazole (“Flagyl”): A radiosensi-tizer of hypoxic cells. Br J Radiol 47:474–481
Asquith JC, Watts ME, Patel K (1974) Electron affinic sensitization. V Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat Res 60:108–118
Beck MDF (1980) Imaging techniques in the diagnosis of radiation damage to the nervous system. In: Gilbert HA, Kagan AR (eds) Radiation damage to the nervous system. A delayed therapeutic hazard. Raven Press, New York, pp 107–128
Bewley DK (1972) Pions and heavy ions in radiotherapy. Nature 237:17–19
Bicher HJ, Hetzel FW, Sandhu TS, Frinak S, Vaupel P, O’Hara M, O’Brian T (1980) Effects of hyperthermia in normal and tumor microenvironment. Radiology 137: 523–530
Bicher HJ, Sandhu TS, Hetzel FW (1980) Hyperthermia and radiation in combination: a clinical fractionation regime. Int J Radiat Oncol Biol Phys 6:861–866
Bleyer WA, Griffin TW (1980) White matter necrosis, mineralizing microangiopathy and intellectual abilities in survivers of childhood leukemia. In: Gilbert HA, Kagan AR (eds) Radiation damage to the nervous system. A delayed therapeutic harzard. Raven Press, New York, pp 59–92
Boldrey E, Sheline G (1967) Delayed transitory clinical manifestations after radiation treatment of intracranial tumors. Acta Radiol 5:5–10
Bouchard J (1973) Central nervous system. In: Fletscher GH (ed) Textbook of radiotherapy, 2nd edn. Lea & Febiger, Philadelphia, pp 366–418
Bryan P (1974) CSF seeding of intra-cranial tumors: A study of 96 cases. Clin Radiol 25:355–360
Bull JWD, Rovit RL (1957) The radiographic localization of intracerebral gliomata. J Fac Radiol 8:147–157
Bush RS, Jenkin RDT, Allt WEC (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37:302–306
Castro JR, Quivey JM (1977) Clinical experience and expectations with Helium and heavy ion irradiation. Int J Radiat Oncol Biol Phys 3:127–131
Catterall M (1977) The results of randomised clinical trials of fast neutrons from the medical research council cyclotron, London. Int J Radiat Oncol Biol Phys 3:247–253
Catterall M, Bloom HJG, Ash DV et al. (1980) Fast neutrons compared with mega-voltage x-rays in the treatment of patients with supratentorial glioblastoma: A controlled pilot study. Int J Radiat Oncol Biol Phys 6:261–266
Caveness WF (1977) Pathology of radiation damage to the normal brain of the monkey. Natl Cancer Inst Monogr 46:57–76
Caveness WF (1980) Experimental observations: Delayed necrosis in normal monkey brain. In: Gilbert HA, Kagan AR (eds) Radiation damage to the nervous system. A delayed therapeutic harzard. Raven Press, New York, pp 1–38
Chang CH (1977) Hyperbaric oxygen and radiation therapy in the management of glioblastoma. Natl Cancer Inst Monogr 46:163–169
Chapman JD, Renvers AP, Borsa J (1973) Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to x-rays. Br J Radiol 46:623–630
Chassard JL, Dutou L, Gérard JP, Papillon J (1976) La radiothérapie post-opératoire des gliomes hémisphériques de l’adulte. J Radiol Electrol Med Nucl 57:391–398
Chauser B, Morris C, Field SB, Lewis PB (1977) The effects of fast neutrons and x-rays on the subependymal layer of the rat brain. Radiology 122:821–823
Churchill-Davidson J, Sanger C, Thomlinson RH (1957) Oxygenation in radiotherapy. II. Clinical application. Br J Radiol 30:406–422
Concannon JP, Kramer S, Berry R (1960) The extent of intracranial gliomata at autopsy and its relationships to techniques used in radiation therapy of brain tumors. AJR 84:99–107
Cottier H (1966) Histopathologic der Wirkung ionisierender Strahlen auf höhere Organismen (Tier und Mensch). In: Zuppinger A (Hrsg) Strahlenbiologie. Springer, Berlin Heidelberg New York (Handbuch der Medizinischen Radiology, Bd. II, S 35–272
Denekamp J, Michael BD (1972) Preferential sensitation of hypoxic cells to radiation in vivo. Nature 239:21–27
Deutsch G, Foster JL, McFazean JA (1975) Human studies with “high dose” metronidozole, a non-toxic radiosensitizer of hypoxic cells. Br J Cancer 31:75–80
Dewey WC, Thrall DE, Gilette EL (1977) Hyperthermia and radiation: A selective thermal effect on chronically hypoxic tumor cells in vivo. Int J Radiat Oncol Biol Phys 2:99–103
Dische S (1978) Hyperbaric oxygen: The medical research council trials and other clinical significance. Br J Radiol 5 1:888–894
Dische S, Saunders MI, Lee ME, Adams GE, Flockhart IR (1977) Clinical testing of radiosensitizer RO-07–0582: Experience with multiple doses. Br J Cancer 35: 567–579
Dische S, Saunders MJ, Flockhart IR, Lee ME, Anderson P (1979) Misonidazole: A drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys 5: 851–860
Druckmann A (1929) Schlafsucht als Folge der Röntgenbestrahlung. Beitrag zur Strahlenempfindlichkeit des Gehirns. Strahlentherapie 33:382–384
Dugle DL, Chapman JD, Gillespie CJ, Borsa J, Webb RG, Meeker BE, Renvers AP (1972) Radiation induced strand breakage in mammalian cell DNA: I. Enhancement of single-strand breaks by chemical radio sensitizers. Int J Radiat Biol Phys 22:545–555
Eddy HA (1980) Alterations in tumor microvasculature during hyperthermia. Radiology 137:515–525
Ellis F (1969) Dose, time and fractionation. A clinical hypothesis. Clin Radiol 20: 1–7
Emami B, Nussbaum GH, Then’Haken RK, Hughes WL (1980) Physiological effects of hyperthermia: Response of capillary blood flow and structures to local tumor heating. Radiology 137:805–809
EORTC (in preparation) Cooperative group for radiotherapy. Double blind study of radiotherapy and misonidazole for high malignant brain tumors.
EORTC (in preparation) Cooperative group for radiotherapy. Multiple daily irradiations for high grade malignant gliomas
Field SB, Hume SP, Law MP, Myers R (1977) The response of tissues to combined hyperthermia and x-rays. Br J Radiol 50:129–134
Fischer AW, Holfelder H (1930) Lokales Amyloid im Gehirn: Eine Spätfolge von Röntgenbestrahlungen. Zentralblatt Chir 277:475
Fletscher GH (1979) Squames cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 5:2073–2090
Foster JL, Willson RL (1973) Radio sensit ation of anoxic cells by metronidazole. Br J Radiol 46:234–235
Franke HD (1973) Die Strahlenempfindlichkeit des Nervensystems. Strahlenschutz Forsch Prax 12:163–194
Franke HD, Lierse W (1978) Strahlenbedingte Reaktionen des Gehirns und des Rückenmarks. Strahlentherapie 174:587–198
Freemann JE, Johnston PGB, Voke JM (1973) Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukemia. Br Med J IV: 523–525
Gangji D, Reaman G, Cohen SR, Bleyer A, Poplack DG (1980) Leukoencephalo-pathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med 303:19–21
Gangji D, Schwade JG, Strong JM (to be published) Phenytoin-Misonidazole: Possible metabolic interaction. Cancer Treat Rep
Gilbert HA, Kagan AR (1980) Preface. In: Gilbert HA, Kagan AR (eds) Radiation damage to the nervous system. A delayed therapeutic hazard. Raven Press, New York
Gray AJ, Dische S, Adams GE, Flockhart IR, Forster JL (1976) Clinical testing of the radio sensitizer RO-07–0582. I. Dose tolerance, serum and tumour concentration. Clin Radiol 27:151–157
Gray LH, Conger AD, Ebert M (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 631–648
Green N, George F (1970) Total brain radiotherapy: Technical considerations. Radiology 96:429–432
Gregersen MJ, Pallavicini C, Chien S (1962) Studies in the chemical composition of the central nervous system in relation to the effects of x-irradiation and of disturbances in water and salt balance. Radiat Res 17:209–225
Gutin PH, Wara WM, Phillips TL, Wilson CB (1980) Hypoxic cell radiosensitizers in the treatment of malignant brain tumors. Neurosurgery 6:567–576
Haase W, Rey G, Wölgens P (1977) Beitrag zur Strahlentherapie der Hirntumoren. Strahlentherapie 153:437–448
Hahn GM (1974) Metabolic aspects of the role of hyperthermia in mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Res 34: 3117–3123
Hall EJ, Biaglow J (1977) RO-07–0582 as a radiosensitizer and cytotoxic agent. Int J Radiat Oncol Biol Phys 2:521–530
Harisiadis L, Hall EJ, Kraljevic U, Borek C (1975) Hyperthermia: Biological studies at the cellular level. Radiology 117:447–452
Harris JR, Levene MB (1976) Visual complications following irradiation, for pituitary adenomas and craniopharyngeomas. Radiology 120:167–171
Hellriegel W (1957) Die Strahlenbehandlung der Hirntumoren. Strahlentherapie 102:21–30
Hevitt HB, Wilson CW (1959) The effect of tissue oxygen tension on the radiosen-sitivity of leukemia cells irradiated in situ in the livers of leukaemic mice. Br J Cancer 13:675–684
Hindo WA, De Trana FA, Lee MS, Hendrickson FR (1970) Large dose increment irradiation in treatment of cerebral metastases. Cancer 26:138–141
Hofer KG, Hofer MG, Ieracitano J, McLaughlin WH (1977) Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitro-imidazoles. Radiat Res 70:362–377
Hoffmann WF, Levin VA, Wilson CB (1979) Evaluation of malignant glioma patients during the postirradiation period. J Neurosurg 50:624–628
Jentzsch K, Kärcher KH, Kogelnik HD et al. (1977) Initial clinical experience with the radiosensitizing nitroimidazole RO-07–0582. Strahlentherapie 153:825–831
Jones A (1964) Transient radiation myelopathy (with reference to Lhermitte’s signe of electrical paresthesia). Br J Radiol 37:727–764
Kagan AR, Wollin M, Gilbert HA, Nussbaum H, Hintz BL, Rao A, Chan PYM (1980) Comparison of the tolerance of the brain and spinal cord to injury by radiations. In: Gilbert HA, Kagan AR (eds) Radiation damage to the nervous system. A delayed therapeutic hazard. Raven Press, New York, pp 183–190
Klatzo I, Miguel J, Tobias C, Haymaker W (1961) Effects of alpha-particle radiation on the rat brain, including vascular permeability and glycogen studies. J Neuropathol Exp Neurol 20:495–472
Kligerman MM, Knapp EA, Petersen DF (1975) Biomedical program leading to therapeutic trials of pion radiation at Los Alamos. Cancer 36:675–680
Kogel AJ van der, Barendsen GW (1979) Late effects of radiation in the spinal cord. Publication of the radiobiological institute. Rijswijk, The Netherlands, pp 118–121
Kogelnik HD, Reinartz G, Szepesi T, Wurst F, Mamoli B, Wessely P, Stark H (1980) Klinische Erfahrungen bei täglicher Gabe von Misonidazol. Strahlentherapie 156: 759–764
Köhn K, Schiungbaum W (1958) Ein Beitrag zur Kenntnis der frühkindlichen Strahlenencephalopathie. Strahlentherapie 107:556–566
Kramer S (1959) Tumor extent as a determining factor in radiotherapy of glioblastomas. Acta Radiol 8:111–117
Kramer S (1968) The hazards of therapeutic irradiation of the central nervous system. Clin Neurosurg 15:301–318
Kramer S, Sauthard ME, Mansfield CM (1972) Radiation effect and tolerance of the central nervous system. Front Radiat Ther Oncol 6:332–345
Lampert PW, Davis RL (1964) Delayed effects of radiation in the human central nervous system: “early and late” delayed reactions. Neurology (NY) 14:912–917
Laramore GE, Griffin TW, Gerdes AJ, Parker RG (1978) Fast neutron and mixed (neutron/photon) beam teletherapy for grades III and IV astrocytomas. Cancer 42: 96–103
Levin VA, Edwards MS, Byrd A (1979) Quantitative observations of the acute effects of x-irradiation on brain capillary permeability: Part I. Int J Radiat Oncol Biol Phys 5:1677–1631
Ley A, Guitard JM (1962) Surgical management of intracranial gliomas. J Neurosurg 19:365–374
Lierse W, Francke HD (1970) Ultrastrukturelle Veränderungen am Gehirn des Meerschweinchens und der Ratte während der Latenzzeit der Strahlenreaktion. Fortschr Röntgenstr 112:151–157
Lindgren M (1958) On tolerance of brain tissue and sensitivity of brain tumours to irradiation. Acta Radiol (Suppl) (Stockh) 170:1–73
Liu HM, Maurer HS, Vongriont S, Conway JJ (1978) Methotrexate encephalopathy. A neuropathology study. Hum Pathol 9:635–648
Marsa GW, Goffinet DR, Rubinstein LJ, Bagshaw MA (1975) Megavoltage irradiation in the treatment of gliomas of the brain and spinal cord. Cancer 36:1681–1689
Maruyama Y, Beach JL, Feola J (1980) Scheduling of hypoxic tumor therapy using neutron brachytherapy. Radiology 137:775–781
Matzukado Y, McCarty CS, Kernohan JW (1961) Growth of glioblastoma multiforme (astrocytoma grade HI and IV) in neurosurgical practice. J Neurosurg 18: 636–644
Mcintosh S, Fischer DB, Rothman S, Rosenfield N, Label JS, O’Brien RT (1977) Intracranial calcification in childhood leukemia. J Pediatr 91:909–913
Meadows AT, Evans AE (1976) Effects of chemotherapy in the central nervous system. Cancer 37:1079–1085
Mikhael MA (1980) Dosimetric considerations in the diagnosis of radiation necrosis of the brain. In: Gilbert HA, Kagan HR (eds) Radiation damage to the nervous system. A delayed hazard. Raven Press, New York, pp 59–92
Milne N, Hill RP, Bush RS (1973) Factors affecting hypoxic KHT tumor cells in mice breathing O2, O2 and CO2, or hyperbaric oxygen with or without anaesthetic. Radiology 106:663–671
Onoyma Y, Abe M, Yabumoto E, Sakamoto T, Nishidai T, Suyama S (1976) Radiation therapy in the treatment of glioblastoma. AJR 126:481–492
Orton CG, Ellis F (1973) A simplification in the use of the NSD concept in practical radiotherapy. Br J Radiol 46:529–537
Parker D, Malpas JS, Sandland R, Sheaff PC, Freeman JE, Paxton A (1978) Outlook following somnolence syndrom after prophylactic cranial irradiation. Br Med J IV:554–559
Parker RG, Berry HC, Gerdes AJ, Soronen MD, Shaw CM (1976) Fast neutron beam radiotherapy of glioblastoma multiforme. AJR 127:331–335
Peylan-Ramu N, Poplack DG, Pizzo PA, Adornato BT, Di Chiro G (1978) Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 298:1815–1818
Pochedly C (1979) Prophylactic CNS-therapy in childhood acute leukemia. Review of methods used. Am J Pediatr Hematol Oncol 1:119–126
Price RA (1979) Histopathology of CNS leukemia and complications of therapy. Am J Pediatr Hematol Oncol 1:21–30
Price RA, Birdwell DA (1978) The central nervous system in childhood leukemia. III. Mineralizing microangiopathy and dystrophic calcification. Cancer 42:717–728
Price RA, Jamilson PA (1975) The central nervous system in childhood leukemia. II. Subacute leucoencephalopathy. Cancer 35:316–318
Putten LM van (1977) Reoxygenation of hypoxic tumor cells. Strahlentherapie 153:380–383
Putten LM van, Kallman RF (1968) Oxygenation status of a transplantable tumor during fractionated radiotherapy. J Natl Cancer Inst 40:441–451
Raju MR, Amolz AJ, Dicello JF et al. (1978) A heavy particle comparative study. Br J Radiol 51:699–703
Rider WD (1963) Radiation damage to the brain. A new syndrome. J Can Assoc Radiol 14:67–69
Rubin P (1969) Extradural spinal cord compression by tumor. I. Experimental production and treatment trial. Radiology 93:1243–1260
Rubin P, Hanley J, Keys HM, Marcial V, Brady L (1979) Carbogen breathing during radiation therapy — the radiation therapy oncology group national study. Int J Radiat Oncol Biol Phys 5:1963–1970
Salazar OM, Rubin P (1976) The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1:627–637
Salazar OM, Rubin P, McDonald JV, Feldstein ML (1976) High dose radiation therapy in the treatment of glioblastomas multiforme: a preliminary report. Int J Radiat Oncol Biol Phys 1:717–727
Salazar OM, Rubin P, Feldstein ML, Pizzutiello R (1979) High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys 5:1733–1740
Schlienger M, Constans JP, Roujeau J, Askienazy S, Eschwege F (1973) Irradiation d’une serie de 304 tumeurs intrakranielles malignes primitives de l’adulte. J Radiol Electrol Med Nucl 54:939–950
Seiler R, Greiner R, Zimmermann A, Markwalder H (1978) Radiotherapy combined with procarbazine, bleomycin and CCNU in the treatment of high-grade supratentorial astrocytomas. J Neurosurg 48:861–865
Sheldon PW, Fowler JF (1979) The effect of recovery from potentially lethal damage on the determination of reoxygenation in a murine tumour. Br J Radiol 52:634–641
Sheline GE (1975) Radiation therapy of primary tumours. Semin Oncol 2:29–42
Sheline GE (1976) The importance of distinguishing tumour grade in malignant gliomas: treatment and prognosis. Int J Radiat Oncol Biol Phys 1:781–786
Sheline GE, Wara WM (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215–1228
Simpson WJ, Platts ME (1976) Fractionation study in the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1:639–644
Song CW, Kang MS, Rhee Juong G, Levitt SH (1980) The effect of hyperthermia on vascular function, pH, and cell survival. Radiology 137:795–803
Sridhar R, Sutherland R (1977) Hyperthermic potentiation of cytotoxicity of Ro-07–0582 in multicell spheroids. Int J Radiat Oncol Biol Phys 2:531–535
Steward FA, Denekamp J (1978) The therapeutic advantage of combined heat and x-rays on a mouse fibrosarcoma. Br J Radiol 51:307–316
Sutherland RM, Franko AJ (1980) On the nature of the radiobiologically hpoxic fraction in tumors. Int J Radiat Oncol Biol Phys 6:117–120
Thomlinson RH, Gray LH (1955) Histological structure of some human lung cancers and possible implications for radiotherapy. Br J Cancer 9:539–549
Thomlinson RH, Dische S, Gray AJ, Errington LM (1976) Clinical testing of the radiosensitizer RO-07–0582. III. Response of tumours. Clin Radiol 27:151–157
Todd IDH (1963) Choice of volume in the x-ray treatment of supratentorial gliomas. Br J Radiol 36:645–649
Turner AR, Allalunis MJ, Urtasun RC, Pedersen JE, Meeker BE (1980) Cytotoxic and radiosensitizing effects of Misonidazole on hematopoiesis in normal and tumor-bearing mice. Int J Radiat Oncol Biol Phys 6:1157–1162
Urtasun R, Band P, Chapman D, Feldstein ML, Mielke B, Fryer C (1976) Radiation and high-dose metronidazole in supratentorial glioblastomas N Engl J Med 294:1364–1367
Urtasun RC, Band P, Chapman D, Rabin H, Wilson F, Fryer CG (1977) Clinical phase I study of the hypoxic cell radiosensitizer RO-07–0582, a 2-nitro-imidazole derivative. Radiology 122:801–804
Walker MD, Strike TA (1979) A phase II evaluation of misonidazole in the treatment of malignant glioma (Abstract). Proc Am Assoc Cancer Res 20:433
Walker MD, Alexander E, Hunt WE et al. (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343
Walker MD, Strike TA, Sheldine GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725–1731
Weichselbaum RR, Epstein J, Little JB, Kornblith P (1976) Inherent cellular radiosensitivity of human tumors of varying clinical curability. AJR 127:1027–1032
Yung W, Steward W, Marks JE, Griem ML, Mullan JF (1976) Glioblastoma multiforme: treatment with radiation and triiodothyronine. Int J Radiat Oncol Biol Phys 1:645–650
Zeman W (1966) Oxygen effect and selectivity of radiolesions in the mammalian neuraxis. Acta Radiol 5:204–216
Zippel RM, Sack H (1979) Nebenwirkungen und Spätfolgen der kombinierten Strahlen- und Chemotherapie des Gehirnschädels bei Kindern mit akuter lympho-blastischer Leukämie (ALL). Strahlentherapie 155:165–170
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Seiler, R.W. (1982). Strahlentherapie. In: Die undifferenzierten Astrozytome des Großhirns. Schriftenreihe Neurologie / Neurology Series, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68505-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-68505-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68506-4
Online ISBN: 978-3-642-68505-7
eBook Packages: Springer Book Archive